Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Neurology · Focal Epilepsy

Treating the Storm: Medication and Care Pathways

At a Glance

Focal sensory seizures are treated with an antiseizure medication selected for the person’s health history and side-effect risks. If seizures continue after two appropriate medication trials, a comprehensive epilepsy center can evaluate options such as surgery or neuromodulation.

Because focal sensory seizures are a form of focal epilepsy, their treatment follows a well-established medical pathway. The primary goal of treatment is complete seizure freedom with the fewest possible side effects [1]. While the sensations may feel different from a typical seizure, the “electrical storm” in the brain is treated using the same classes of antiseizure medications (ASMs).

Choosing Your First Medication

There is no single “best” drug for everyone. Instead, your doctor will select a medication based on your age, other health conditions, reproductive plans, and your personal risk for specific side effects [1][2].

Commonly used first-line options include:

  • Lamotrigine: Often favored for its high tolerability and positive effect on mood [1][3]. It must be started at a very low dose and increased slowly over several weeks to prevent a rare but serious skin rash [1]. (Urgent: Seek immediate medical care if you develop a rash with fever, blisters, mouth sores, eye sores, or rapid spread.)
  • Levetiracetam: A common choice because it can be started at a therapeutic dose quickly and has few interactions with other drugs [4]. However, it may cause severe irritability, depression, or suicidal thoughts in some people, particularly those with a history of depression or anxiety, requiring urgent medical attention [5][6].
  • Oxcarbazepine: Highly effective for focal seizures but requires monitoring of your blood sodium levels, which can sometimes drop (hyponatremia) while taking this medication [7][8]. Extreme fatigue or confusion warrant evaluation.
  • Lacosamide: A newer option that is generally well-tolerated and often used as either a first-line treatment or an “add-on” if the first drug doesn’t fully work [9][10].

Pregnancy and Contraception

If you are capable of becoming pregnant, preconception planning is critical. Certain ASMs interact with hormonal birth control or carry risks for fetal development. Discuss reproductive plans with your prescriber.

What to Expect: The Treatment Timeline

Starting a new medication is a gradual process. You will go through a period of titration, where your dose is slowly increased to find the “sweet spot” where seizures stop but side effects are minimal [11]. The timeline is individualized.

  • Initial Phase: This is typically the titration phase. You may feel more tired or “foggy” during this time as your brain adjusts to the medication [11]. Never stop or taper an antiseizure medication abruptly without a plan from your prescriber.
  • Months 2–6: Once you reach a stable dose, your doctor will monitor you to see if the sensory seizures have stopped completely [12].
  • One Year: While 12 months without seizures is sometimes used as a benchmark for driving clearance or research, treatment success and remission definitions vary widely [13][12].

Success Rates and the “Rule of Two”

For many people, the first medication they try is the only one they will ever need.

  • The First Trial: Approximately 50% to 67% of people with newly diagnosed focal epilepsy achieve complete seizure freedom with their very first appropriate medication [14][15]. (These rates vary with diagnosis accuracy and adherence).
  • The Second Trial: If the first drug doesn’t work or causes too many side effects, your doctor will switch you to a second medication or add a second one. This often brings another group of patients into seizure freedom [16][17].

When to Seek Specialized Care

If your sensory seizures continue after you have tried two different appropriately chosen, tolerated, and adequately dosed medications with reasonable adherence, the condition is classified as drug-resistant epilepsy [11][18]. At this stage, trying a third or fourth medication is less likely to result in total seizure freedom (only about 1% to 3% success rate for additional drugs) [19].

If you reach this point, international guidelines recommend a prompt referral to a Comprehensive Epilepsy Center [20]. This is an opportunity for a detailed review, not an automatic commitment to surgery. Specialists there can evaluate you for advanced options, such as:

  • Epilepsy Surgery: Removing the small area of the brain where the seizures start—which can be curative in well-selected candidates [21][22].
  • Neuromodulation: Devices like VNS (Vagus Nerve Stimulation) or RNS (Responsive Neurostimulation) that use electrical pulses to help interrupt seizures before they spread [22][23].

A Note on Consistency

Using a pillbox, a phone alarm, or a seizure tracking app can significantly improve your chances of reaching the goal: total seizure freedom [24]. While missed doses can cause breakthrough seizures, ongoing events despite appropriate use reflect genuine drug resistance. Follow your prescriber’s specific instructions if you miss a dose.

Common questions in this guide

Which medicine is usually tried first for focal sensory seizures?
There is no single best medication for everyone. Clinicians may consider lamotrigine, levetiracetam, oxcarbazepine, or lacosamide based on your age, other health conditions, reproductive plans, medication interactions, and likely side effects.
How long does it take to find the right seizure medication dose?
The dose is usually increased gradually over several weeks while your body adjusts and side effects are assessed. After reaching a stable dose, your clinician may monitor you for several months to determine whether the sensory seizures have stopped. Do not stop or taper the medication abruptly without a prescriber's plan.
What medication side effects require urgent medical attention?
A rash with fever, blisters, mouth or eye sores, or rapid spread while taking lamotrigine requires immediate medical care. Severe irritability, depression, or suicidal thoughts while taking levetiracetam also need urgent attention, while extreme fatigue or confusion with oxcarbazepine should be evaluated because blood sodium can fall.
What should I discuss about pregnancy or birth control before starting treatment?
Tell your prescriber about pregnancy plans and current contraception before choosing an antiseizure medication. Some medicines can interact with hormonal birth control or increase risks to fetal development, so preconception planning is important.
What does drug-resistant epilepsy mean?
Drug-resistant epilepsy means seizures continue after two appropriately chosen, tolerated, and adequately dosed antiseizure medications have been tried with reasonable adherence. It is a reason to seek specialized evaluation, not a sign that no treatment options remain.
When should I be referred to a comprehensive epilepsy center?
A prompt referral is recommended when focal sensory seizures continue after two appropriate medication trials. Specialists can review the diagnosis and treatment and evaluate options such as epilepsy surgery, vagus nerve stimulation, or responsive neurostimulation; referral does not automatically mean surgery is required.
How can I avoid missed doses of my seizure medication?
A pillbox, phone alarm, or seizure-tracking app can help you take medication consistently. Missed doses may trigger breakthrough seizures, so follow your prescriber's specific instructions if you miss one rather than making up a dose on your own.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific antiseizure medication are you recommending as my first-line option, and why is it the best fit for my health history?
  2. 2.How will we manage the titration—the slow increase in dose—to minimize my risk of side effects?
  3. 3.If I have a history of mood changes or anxiety, is levetiracetam still a safe option for me, or should we consider an alternative like lamotrigine?
  4. 4.At what dose will we consider this a 'full trial' of the medication before deciding if it works or if we need to switch?
  5. 5.If my sensory seizures don't stop after this first medication, what is our next step in the treatment plan?
  6. 6.Are there specific long-term health markers, like bone density or sodium levels, that we need to monitor while I am on this medication?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

    Nevitt SJ, Sudell M, Cividini S, et al.

    The Cochrane database of systematic reviews 2022; (4()):CD011412 doi:10.1002/14651858.CD011412.pub4.

    PMID: 35363878
  2. 2

    Epilepsy treatment in adults and adolescents: Expert opinion, 2016.

    Shih JJ, Whitlock JB, Chimato N, et al.

    Epilepsy & behavior : E&B 2017; (69()):186-222 doi:10.1016/j.yebeh.2016.11.018.

    PMID: 28237319
  3. 3

    Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.

    Campos MS, Ayres LR, Morelo MR, et al.

    Pharmacotherapy 2016; (36(12)):1255-1271 doi:10.1002/phar.1855.

    PMID: 27779771
  4. 4

    Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

    Kanner AM, Ashman E, Gloss D, et al.

    Epilepsy currents 2018; (18(4)):260-268 doi:10.5698/1535-7597.18.4.260.

    PMID: 30254527
  5. 5

    The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy.

    Barnard SN, Chen Z, Kanner AM, et al.

    Neurology 2024; (103(7)):e209821 doi:10.1212/WNL.0000000000209821.

    PMID: 39270150
  6. 6

    Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.

    Stephen LJ, Wishart A, Brodie MJ

    Epilepsy & behavior : E&B 2017; (71(Pt A)):73-78 doi:10.1016/j.yebeh.2017.04.003.

    PMID: 28551500
  7. 7

    Oxcarbazepine add-on for drug-resistant focal epilepsy.

    Bresnahan R, Atim-Oluk M, Marson AG

    The Cochrane database of systematic reviews 2020; (3()):CD012433 doi:10.1002/14651858.CD012433.pub2.

    PMID: 32129501
  8. 8

    Antiseizure Medications for Adults With Epilepsy: A Review.

    Kanner AM, Bicchi MM

    JAMA 2022; (327(13)):1269-1281 doi:10.1001/jama.2022.3880.

    PMID: 35380580
  9. 9

    Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy.

    Hoy SM

    CNS drugs 2018; (32(5)):473-484 doi:10.1007/s40263-018-0523-7.

    PMID: 29785508
  10. 10

    Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.

    Lattanzi S, Zaccara G, Giovannelli F, et al.

    Acta neurologica Scandinavica 2019; (139(1)):33-41 doi:10.1111/ane.13025.

    PMID: 30194755
  11. 11

    Treatment Response to Antiseizure Medications in People With Newly Diagnosed Focal Epilepsy.

    Barnard SN, Chen Z, Holmes M, et al.

    JAMA neurology 2025; (82(10)):1022-1030 doi:10.1001/jamaneurol.2025.2949.

    PMID: 40853673
  12. 12

    Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open-label Study 342 (FREEDOM Study).

    Yamamoto T, Lim SC, Ninomiya H, et al.

    Epilepsia open 2020; (5(2)):274-284 doi:10.1002/epi4.12398.

    PMID: 32524053
  13. 13

    Efficacy and safety of perampanel monotherapy in Chinese children with newly diagnosed focal epilepsy: a single-center prospective study.

    Hong Y, Lu Y, Chen H, Liu Z

    Translational pediatrics 2025; (14(10)):2758-2764 doi:10.21037/tp-2025-396.

    PMID: 41216460
  14. 14

    Response to first antiseizure medication in patients diagnosed with epilepsy.

    Hersi H, Saarinen JT, Raitanen J, Peltola J

    Acta neurologica Scandinavica 2021; (144(1)):67-75 doi:10.1111/ane.13426.

    PMID: 33835491
  15. 15

    Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.

    Chen Z, Brodie MJ, Liew D, Kwan P

    JAMA neurology 2018; (75(3)):279-286 doi:10.1001/jamaneurol.2017.3949.

    PMID: 29279892
  16. 16

    Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.

    Zou XM, Chen JN, An DM, et al.

    Seizure 2015; (29()):81-5.

    PMID: 26076847
  17. 17

    Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy.

    Hersi H, Saarinen JT, Raitanen J, Peltola J

    Frontiers in neurology 2022; (13()):1042168 doi:10.3389/fneur.2022.1042168.

    PMID: 36438960
  18. 18

    Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy.

    Bruun E, Kälviäinen R, Keränen T

    Epilepsy research 2016; (127()):60-65 doi:10.1016/j.eplepsyres.2016.08.023.

    PMID: 27565412
  19. 19

    Validated outcome of treatment changes according to International League Against Epilepsy criteria in adults with drug-resistant focal epilepsy.

    Mula M, Zaccara G, Galimberti CA, et al.

    Epilepsia 2019; (60(6)):1114-1123 doi:10.1111/epi.14685.

    PMID: 30866058
  20. 20

    Focal epilepsies: Update on diagnosis and classification.

    Nascimento FA, Friedman D, Peters JM, et al.

    Epileptic disorders : international epilepsy journal with videotape 2023; (25(1)):1-17 doi:10.1002/epd2.20045.

    PMID: 36938903
  21. 21

    Epilepsy surgery.

    Rugg-Gunn F, Miserocchi A, McEvoy A

    Practical neurology 2020; (20(1)):4-14 doi:10.1136/practneurol-2019-002192.

    PMID: 31420415
  22. 22

    Putting it all together: Options for intractable epilepsy: An updated algorithm on the use of epilepsy surgery and neurostimulation.

    Benbadis SR, Geller E, Ryvlin P, et al.

    Epilepsy & behavior : E&B 2018; (88S()):33-38 doi:10.1016/j.yebeh.2018.05.030.

    PMID: 30241957
  23. 23

    Comparison and Selection of Current Implantable Anti-Epileptic Devices.

    Wong S, Mani R, Danish S

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2019; (16(2)):369-380 doi:10.1007/s13311-019-00727-2.

    PMID: 31062294
  24. 24

    Seizure Detection Devices.

    Baumgartner C, Baumgartner J, Lang C, et al.

    Journal of clinical medicine 2025; (14(3)) doi:10.3390/jcm14030863.

    PMID: 39941534

This page is for informational purposes only and does not constitute medical advice about focal sensory seizures. Your neurologist or epilepsy specialist should tailor medication and care decisions to your health history.

Get notified when new evidence is published on partial sensory epilepsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.